Yixuan Yang
Research Subjects
Yixuan Yang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Ashour Ahmed
MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
1 shared publication - Buri Xi
Westlake Laboratory of Life Sciences and Biomedicine
1 shared publication Guanglei Zhuang
State Key Laboratory of Systems Medicine for Cancer, Shanghai Key Laboratory of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
1 shared publicationHai Gong
Institute of Cyber-Systems and Control, College of Control Science and Engineering, Zhejiang University
1 shared publication- Jinyu He
College of Life Sciences, Nanjing Agricultural University , Nanjing 210095
1 shared publication - Junqi Hou
College of Life Sciences Nanjing Agricultural University Nanjing 210095 China
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (46)
The p38α MAPK–MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression
Nuclear F-actin facilitates DNA damage repair and contributes to cancer chemoresistance. However, the regulatory mechanisms controlling its dynamic polymerization in response to genotoxic stress remain poorly defined. A major barrier in nuclear actin research is the lack of tools for precise, high-throughput analysis. To systematically investigate nuclear F-actin assembly in DNA damage response, we developed a deep learning pipeline, named nFANet, for high-throughput detection and analysis of nuclear F-actin. Here, using ovarian cancer—a malignancy where chemoresistance is a major clinical obstacle—as a model, we showed that platinum-based chemotherapy robustly induces nuclear F-actin assembly. A subsequent kinome screening, in combination with the application of nFANet, identified the kinase p38α MAPK as a critical upstream regulator of platinum-induced nuclear F-actin assembly. Mechanistically, the p38α MAPK–MK2 signaling pathway promotes formin-mediated nuclear F-actin assembly in response to chemotherapy. Importantly, pharmacological inhibition or genetic knockout of the p38α MAPK–MK2 pathway sensitized ovarian cancer cells to platinum-based therapy. Our work uncovers a key mechanism governing nuclear actin remodeling under genotoxic stress and lays the foundation for identifying a patient subgroup likely to benefit from therapeutic targeting of this pathway.
- 12 November 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (46)
Open AccessThe p38α MAPK–MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression
Nuclear F-actin facilitates DNA damage repair and contributes to cancer chemoresistance. However, the regulatory mechanisms controlling its dynamic polymerization in response to genotoxic stress remain poorly defined. A major barrier in nuclear actin research is the lack of tools for precise, high-throughput analysis. To systematically investigate nuclear F-actin assembly in DNA damage response, we developed a deep learning pipeline, named nFANet, for high-throughput detection and analysis of nuclear F-actin. Here, using ovarian cancer—a malignancy where chemoresistance is a major clinical obstacle—as a model, we showed that platinum-based chemotherapy robustly induces nuclear F-actin assembly. A subsequent kinome screening, in combination with the application of nFANet, identified the kinase p38α MAPK as a critical upstream regulator of platinum-induced nuclear F-actin assembly. Mechanistically, the p38α MAPK–MK2 signaling pathway promotes formin-mediated nuclear F-actin assembly in response to chemotherapy. Importantly, pharmacological inhibition or genetic knockout of the p38α MAPK–MK2 pathway sensitized ovarian cancer cells to platinum-based therapy. Our work uncovers a key mechanism governing nuclear actin remodeling under genotoxic stress and lays the foundation for identifying a patient subgroup likely to benefit from therapeutic targeting of this pathway.
- 10 February 2026
- Published by Wiley in Journal of Integrative Plant Biology
- Vol. 68 (6) , 1607-1609
PBS1 in heat‐immunity crosstalk
The BARELY ANY MERISTEM 1-AVRPPHB SUSCEPTIBLE 1 (PBS1) module is an early plasma membrane switch activating reactive oxygen species-dependent heat responses. PBS1 may integrate heat and immunity, offering targets for breeding climate-resilient crops.
- 10 February 2026
- Published by Wiley in Journal of Integrative Plant Biology
- Vol. 68 (6) , 1607-1609
PBS1 in heat‐immunity crosstalk
The BARELY ANY MERISTEM 1-AVRPPHB SUSCEPTIBLE 1 (PBS1) module is an early plasma membrane switch activating reactive oxygen species-dependent heat responses. PBS1 may integrate heat and immunity, offering targets for breeding climate-resilient crops.